Javascript must be enabled to continue!
ODP417 Kisspeptin directly stimulates estrogen and progesterone secretion from human granulosa cells.
View through CrossRef
Abstract
Kisspeptin is a peptide hormone that has a central role to stimulate gonadotropin-releasing hormone secretion from the hypothalamus. Furthermore, it was shown to have peripheral roles on enhancing CYP19 (aromatase) expression and aromatase secretion from human granulosa cells (1). The objectives of this study were to determine direct effects of kisspeptin treatment on estrogen and progesterone secretion from human granulosa-like tumor cell line (KGN). KGN cells (n=3) were treated with 10 nM follicle stimulating hormone (FSH); 100, 1,000, and 10,000 nM kisspeptin; and FSH together with different doses of kisspeptin for 24 hours. Estrogen and progesterone concentrations in supernatant were measured by enzyme immunoassay kits. The results showed that FSH treatment alone (P<0. 05) and FSH together with 100 (P<0. 01), 1,000 (P<0. 001), and 10,000 (P<0. 001) nM kisspeptin increased estrogen concentrations in supernatants when compared to control. Kisspeptin treatment alone did not increase estrogen concentrations in supernatant when compared to control. Interestingly, kisspeptin treatment at 1,000 (P<0. 01) and 10,000 (P<0. 01) nM together with FSH enhanced estrogen concentrations in supernatant when compared to FSH treatment alone. Furthermore, FSH treatment alone (P<0. 05) and FSH together with kisspeptin at doses of 1,000 (P<0. 001) and 10,000 (P<0. 05) nM increased progesterone concentrations in supernatant when compared to control. All doses of kisspeptin did not increase progesterone concentrations in supernatant when compared to control. Only 1,000 nM kisspeptin together with FSH enhanced progesterone secretion in supernatant when compared to FSH alone (P<0. 01). Taken together, FSH stimulated estrogen and progesterone secretion from human granulosa cells and kisspeptin enhanced these effects in addition to the effects of FSH alone. Further studies are required to determine whether kisspeptin treatment can restore the functions of unresponsive or partially responsive granulosa cells of aging humans to secrete estrogen and progesterone as well as kisspeptin is useful in augmenting infertility treatment. Reference: (1) Qin L, Sitticharoon C, Petyim S, Keadkraichaiwat I, Sririwichitchai R, Maikeaw P, et al. Exp Biol Med (Maywood). 2021;246(8): 996-1010.
Presentation: No date and time listed
Title: ODP417 Kisspeptin directly stimulates estrogen and progesterone secretion from human granulosa cells.
Description:
Abstract
Kisspeptin is a peptide hormone that has a central role to stimulate gonadotropin-releasing hormone secretion from the hypothalamus.
Furthermore, it was shown to have peripheral roles on enhancing CYP19 (aromatase) expression and aromatase secretion from human granulosa cells (1).
The objectives of this study were to determine direct effects of kisspeptin treatment on estrogen and progesterone secretion from human granulosa-like tumor cell line (KGN).
KGN cells (n=3) were treated with 10 nM follicle stimulating hormone (FSH); 100, 1,000, and 10,000 nM kisspeptin; and FSH together with different doses of kisspeptin for 24 hours.
Estrogen and progesterone concentrations in supernatant were measured by enzyme immunoassay kits.
The results showed that FSH treatment alone (P<0.
05) and FSH together with 100 (P<0.
01), 1,000 (P<0.
001), and 10,000 (P<0.
001) nM kisspeptin increased estrogen concentrations in supernatants when compared to control.
Kisspeptin treatment alone did not increase estrogen concentrations in supernatant when compared to control.
Interestingly, kisspeptin treatment at 1,000 (P<0.
01) and 10,000 (P<0.
01) nM together with FSH enhanced estrogen concentrations in supernatant when compared to FSH treatment alone.
Furthermore, FSH treatment alone (P<0.
05) and FSH together with kisspeptin at doses of 1,000 (P<0.
001) and 10,000 (P<0.
05) nM increased progesterone concentrations in supernatant when compared to control.
All doses of kisspeptin did not increase progesterone concentrations in supernatant when compared to control.
Only 1,000 nM kisspeptin together with FSH enhanced progesterone secretion in supernatant when compared to FSH alone (P<0.
01).
Taken together, FSH stimulated estrogen and progesterone secretion from human granulosa cells and kisspeptin enhanced these effects in addition to the effects of FSH alone.
Further studies are required to determine whether kisspeptin treatment can restore the functions of unresponsive or partially responsive granulosa cells of aging humans to secrete estrogen and progesterone as well as kisspeptin is useful in augmenting infertility treatment.
Reference: (1) Qin L, Sitticharoon C, Petyim S, Keadkraichaiwat I, Sririwichitchai R, Maikeaw P, et al.
Exp Biol Med (Maywood).
2021;246(8): 996-1010.
Presentation: No date and time listed.
Related Results
MON-012 The Direct Effect of Kisspeptin on Human Ovarian Granulosa Cells to Regulate Steroidogenesis
MON-012 The Direct Effect of Kisspeptin on Human Ovarian Granulosa Cells to Regulate Steroidogenesis
Abstract
Kisspeptin has a central role to stimulate the hypothalamic-pituitary-gonadal (HPG) axis. Furthermore, a previous study has suggested that kisspeptin might ...
SAT-658 Associations of Serum and CSF Kisspeptin Levels with Metabolic and Reproductive Parameters in Men
SAT-658 Associations of Serum and CSF Kisspeptin Levels with Metabolic and Reproductive Parameters in Men
Abstract
Action of kisspeptin in the central nervous system (CNS) is well known on reproductive regulation; however, its peripheral action is not well understood. Re...
Abstract 5758: Elevated level of estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
Abstract 5758: Elevated level of estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
Abstract
Effectiveness of chemotherapy depends on the age of breast cancer patients. Breast tissues are estrogen sensitive and the levels of ovarian estrogen are age...
Abstract 1201: Role of the chemokine CXCL12 in the estrogen response of breast cancer cells
Abstract 1201: Role of the chemokine CXCL12 in the estrogen response of breast cancer cells
Abstract
The purpose of this study was to investigate the extent to which CXCL12 mediates the effects of estrogen in estrogen-responsive breast cancer cells. Express...
P-614 Endometrial preparation: effect of estrogen levels before the embryo transfer on the live birth rate from 14825 freezing-all cycles
P-614 Endometrial preparation: effect of estrogen levels before the embryo transfer on the live birth rate from 14825 freezing-all cycles
Abstract
Study question
Is there a difference in live birth rate during discrepant estrogen levels before the embryo transfer fo...
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract 1807: Inter-individual variation in response to estrogen in the mammary gland
Abstract
Background: Previous research has highlighted the paradoxical nature of estrogen in both contributing to and reducing the risk of breast cancer. Exposure to...
Regulation of Bovine Corpus Luteum Function
Regulation of Bovine Corpus Luteum Function
The main goal of this research plan was to elucidate regulatory mechanisms controlling the development, function of the bovine corpus luteum (CL). The CL contains two different ste...
Factors contributing to the absence of post-weaning estrus in hyperprolific sows and their treatment using prostaglandin F2α
Factors contributing to the absence of post-weaning estrus in hyperprolific sows and their treatment using prostaglandin F2α
Currently, a growing concern in the swine production sector is the increasing number of sows that fail to return to estrus within 7 days after weaning. The objectives of this study...

